Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions.
about
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegalyHow sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodiesANA IIF Automation: Moving towards Harmonization? Results of a Multicenter StudyIn control? IQC consensus and statutory regulation.Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Emergence of the Solution to an Important Unmet Need.Laboratory services: regaining and maintaining control.IGF-I levels reflect hypopituitarism severity in adults with pituitary dysfunction.Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug development.Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults.Missed detection of significant positive and negative shifts in gentamicin assay: implications for routine laboratory quality practices.Trends in surgery, hospital admissions and imaging for pituitary adenomas in Australia.Addressing the challenges of biomarker calibration standards in ligand-binding assays: a European Bioanalysis Forum perspective.Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L.Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study.Generating method-specific Reference Ranges - A harmonious outcome?
P2860
Q26777682-8E677A72-D936-4E26-9B3C-9B03C24C6ED8Q34134307-42F205E0-7D4D-4E29-877C-BF4B7FB7F37CQ37683418-B000FBD8-9FB0-451C-8218-682124A32AD7Q38852327-18940D30-517F-4CE3-8880-73A5F154F68CQ39341047-38247D62-30F0-43AC-B16B-1AD3754277DAQ39713312-92B719DA-87D9-4D89-9D23-0BA3E5A8544BQ39847777-E45BA0B1-261E-4AB3-BF68-3C737306E634Q41536252-692BF42E-60BC-4282-8B7A-7533C9C7435CQ41584061-DA600C6C-314F-426B-A3DE-A75B298577C8Q42370216-FF14086F-43BC-4AB1-B70A-75C61762F4DAQ47118057-E5295EDA-52ED-49F3-BD2C-3C5EAA1C4F12Q47657626-C169AF5A-0A72-49AF-AD02-9E6E838DC848Q47748457-8CB623E5-F3F6-4ED3-9279-415A4B89FB12Q49610748-9A589526-8184-418C-9AE0-624608B1882BQ50017693-704C691E-D313-4C1F-B07A-4E45843475F7Q53259297-58D601FE-34F9-474D-B45D-32A9FCFB3611
P2860
Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Failure of current laboratory ...... ndings and possible solutions.
@ast
Failure of current laboratory ...... ndings and possible solutions.
@en
type
label
Failure of current laboratory ...... ndings and possible solutions.
@ast
Failure of current laboratory ...... ndings and possible solutions.
@en
prefLabel
Failure of current laboratory ...... ndings and possible solutions.
@ast
Failure of current laboratory ...... ndings and possible solutions.
@en
P2093
P1433
P1476
Failure of current laboratory ...... ndings and possible solutions.
@en
P2093
Alicia Algeciras-Schimnich
David E Bruns
James C Boyd
Kristin A La Fortune
Sandra C Bryant
Stefan K G Grebe
P304
P356
10.1373/CLINCHEM.2013.205070
P407
P577
2013-04-16T00:00:00Z